Old Web
English
Sign In
Acemap
>
Paper
>
FP16.03 Early Circulating-Tumor DNA EGFR Mutation Clearance in Plasma as a Predictor of Clinical Outcomes in The AURA3 Trial
FP16.03 Early Circulating-Tumor DNA EGFR Mutation Clearance in Plasma as a Predictor of Clinical Outcomes in The AURA3 Trial
2021
Myung-Ju Ahn
Ryan J. Hartmaier
Yi-Long Wu
J. Y. Han
Hiroaki Akamatsu
Thomas John
J.C-H. Yang
Frances A. Shepherd
Angelo Delmonte
X Huang
A. Mellemgaard
Aleksandra Markovets
Juliann Chmielecki
S.S. Ramalingam
Keywords:
egfr mutation
Cancer research
Medicine
Circulating tumor DNA
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]